Clinical Trial Update: ACTHAR Gel for Drug REsistant Nephrotic Syndrome in Children [Phase 4]

View source ↗

Summary

Phase 4 trial for ACTHAR Gel in drug-resistant nephrotic syndrome in children has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Steroid-resistant Nephrotic Syndrome

Drugs mentioned

• Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: Rhode Island Hospital | Conditions: Steroid-Resistant Nephrotic Syndrome | Phase 4 | Status: WITHDRAWN